• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有更高特异性的miRNA样双链体作为RNA干扰触发物。

miRNA-like duplexes as RNAi triggers with improved specificity.

作者信息

Betancur Juan G, Yoda Mayuko, Tomari Yukihide

机构信息

Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan.

出版信息

Front Genet. 2012 Jul 12;3:127. doi: 10.3389/fgene.2012.00127. eCollection 2012.

DOI:10.3389/fgene.2012.00127
PMID:22807929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3395129/
Abstract

siRNA duplexes, the most common triggers of RNA interference, are first loaded into an Argonaute (Ago) protein and then undergo unwinding via passenger strand cleavage, which requires the slicer activity of the Ago protein. In mammals, only Ago2 out of the four Ago proteins possesses such slicer activity. In contrast, miRNA/miRNA* duplexes often contain central mismatches that prevent slicer-dependent unwinding. Instead, mismatches in specific regions (seed and 3'-mid regions) promote efficient slicer-independent unwinding by any of the four mammalian Ago proteins. Both slicer-dependent and slicer-independent unwinding mechanisms produce guide-containing RNA-induced silencing complex (RISC), which silences target mRNAs by cleavage, translational repression, and/or deadenylation that leads to mRNA decay. In this review, we summarize our current knowledge of the RISC assembly pathways, and describe a simple method to rationally design artificial miRNA/miRNA*-like duplexes and highlight its benefits to reduce the unwanted "off-target" effects without compromising the specific target silencing activity.

摘要

小干扰RNA双链体是RNA干扰最常见的触发因素,首先被装载到AGO蛋白中,然后通过乘客链切割进行解旋,这需要AGO蛋白的切割活性。在哺乳动物中,四种AGO蛋白中只有AGO2具有这种切割活性。相比之下,微小RNA/微小RNA双链体通常含有中央错配,可阻止依赖切割的解旋。相反,特定区域(种子区和3' - 中间区)的错配可促进四种哺乳动物AGO蛋白中的任何一种进行高效的非依赖切割解旋。依赖切割和解旋的解旋机制都会产生含向导链的RNA诱导沉默复合体(RISC),该复合体通过切割、翻译抑制和/或去腺苷酸化使靶标信使核糖核酸沉默,从而导致信使核糖核酸降解。在本综述中,我们总结了目前对RISC组装途径的认识,并描述了一种合理设计人工微小RNA/微小RNA样双链体的简单方法,并强调了其在不影响特异性靶标沉默活性的情况下减少不必要的“脱靶”效应的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b76/3395129/91ac30cd63d0/fgene-03-00127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b76/3395129/24be07394cc2/fgene-03-00127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b76/3395129/91ac30cd63d0/fgene-03-00127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b76/3395129/24be07394cc2/fgene-03-00127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b76/3395129/91ac30cd63d0/fgene-03-00127-g002.jpg

相似文献

1
miRNA-like duplexes as RNAi triggers with improved specificity.具有更高特异性的miRNA样双链体作为RNA干扰触发物。
Front Genet. 2012 Jul 12;3:127. doi: 10.3389/fgene.2012.00127. eCollection 2012.
2
Structural determinants of miRNAs for RISC loading and slicer-independent unwinding.微小RNA(miRNA)用于RNA诱导沉默复合体(RISC)加载和不依赖核酸酶切割的解旋的结构决定因素。
Nat Struct Mol Biol. 2009 Sep;16(9):953-60. doi: 10.1038/nsmb.1630. Epub 2009 Aug 16.
3
Slicer function of Drosophila Argonautes and its involvement in RISC formation.果蝇AGO蛋白的切割功能及其在RISC形成中的作用
Genes Dev. 2005 Dec 1;19(23):2837-48. doi: 10.1101/gad.1370605. Epub 2005 Nov 14.
4
The N domain of Argonaute drives duplex unwinding during RISC assembly.Argonaute 的 N 结构域在 RISC 组装过程中驱动双链解旋。
Nat Struct Mol Biol. 2012 Jan 10;19(2):145-51. doi: 10.1038/nsmb.2232.
5
Slicer-independent mechanism drives small-RNA strand separation during human RISC assembly.不依赖切片机的机制在人类RISC组装过程中驱动小RNA链分离。
Nucleic Acids Res. 2015 Oct 30;43(19):9418-33. doi: 10.1093/nar/gkv937. Epub 2015 Sep 17.
6
Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins.人类AGO蛋白不同的过客链及mRNA切割活性
Nat Struct Mol Biol. 2009 Dec;16(12):1259-66. doi: 10.1038/nsmb.1712. Epub 2009 Nov 29.
7
Slicing-independent RISC activation requires the argonaute PAZ domain.不依赖于切割的 RISCs 的激活需要 Argonaute 的 PAZ 结构域。
Curr Biol. 2012 Aug 21;22(16):1536-42. doi: 10.1016/j.cub.2012.06.040. Epub 2012 Jul 12.
8
Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.含核糖二氟甲苯基核苷酸的寡核糖核苷酸的晶体结构、稳定性及体外RNA干扰活性:对人RNA诱导沉默复合体AGO2酶底物需求的深入了解
Nucleic Acids Res. 2007;35(19):6424-38. doi: 10.1093/nar/gkm664. Epub 2007 Sep 18.
9
ATP-dependent human RISC assembly pathways.依赖于 ATP 的人类 RISCs 组装途径。
Nat Struct Mol Biol. 2010 Jan;17(1):17-23. doi: 10.1038/nsmb.1733. Epub 2009 Dec 6.
10
Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.在RNAi复合物组装过程中,Ago2将前体RISC转化为全酶RISC。
RNA. 2007 Jan;13(1):22-9. doi: 10.1261/rna.283207. Epub 2006 Nov 22.

引用本文的文献

1
Non-coding RNAs and neuroinflammation: implications for neurological disorders.非编码RNA与神经炎症:对神经系统疾病的影响
Exp Biol Med (Maywood). 2024 Feb 28;249:10120. doi: 10.3389/ebm.2024.10120. eCollection 2024.
2
Chemical modification patterns for microRNA therapeutic mimics: a structure-activity relationship (SAR) case-study on miR-200c.miRNA 治疗模拟物的化学修饰模式:miR-200c 的结构-活性关系(SAR)案例研究。
Nucleic Acids Res. 2024 Apr 12;52(6):2792-2807. doi: 10.1093/nar/gkae141.
3
Integrated transcriptome and small RNA sequencing in revealing miRNA-mediated regulatory network of floral bud break in .

本文引用的文献

1
Structure of yeast Argonaute with guide RNA.酵母 Argonaute 与引导 RNA 的结构。
Nature. 2012 Jun 20;486(7403):368-74. doi: 10.1038/nature11211.
2
The structure of human argonaute-2 in complex with miR-20a.人 Argonaute-2 与 miR-20a 复合物的结构。
Cell. 2012 Jul 6;150(1):100-10. doi: 10.1016/j.cell.2012.05.017. Epub 2012 Jun 7.
3
The crystal structure of human Argonaute2.人源 Argonaute2 的晶体结构
整合转录组和小RNA测序以揭示……花芽萌发的miRNA介导调控网络
Front Plant Sci. 2022 Jul 22;13:931454. doi: 10.3389/fpls.2022.931454. eCollection 2022.
4
Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming.内皮细胞外囊泡通过肿瘤相关巨噬细胞重编程促进肿瘤生长。
J Extracell Vesicles. 2022 Jun;11(6):e12228. doi: 10.1002/jev2.12228.
5
Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth.抑制线粒体蛋白 Opa1 可抑制乳腺癌生长。
J Exp Clin Cancer Res. 2022 Mar 12;41(1):95. doi: 10.1186/s13046-022-02304-6.
6
Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy and in Mice and Nonhuman Primates.高效且精准的处理亨廷顿病降低腺相关病毒基因治疗中的优化初级人工 microRNA 及其在小鼠和非人灵长类动物中的应用。
Hum Gene Ther. 2022 Jan;33(1-2):37-60. doi: 10.1089/hum.2021.221. Epub 2022 Jan 10.
7
Proximity proteomics identifies PAK4 as a component of Afadin-Nectin junctions.临近蛋白质组学鉴定 PAK4 为 Afadin-Nectin 连接的一个组成部分。
Nat Commun. 2021 Sep 7;12(1):5315. doi: 10.1038/s41467-021-25011-w.
8
Identification of a novel endogenous long non-coding RNA that inhibits selenoprotein P translation.一种抑制硒蛋白P翻译的新型内源性长链非编码RNA的鉴定。
Nucleic Acids Res. 2021 Jul 9;49(12):6893-6907. doi: 10.1093/nar/gkab498.
9
hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells.hnRNPA2B1 抑制内皮细胞中 miR-503 的外泌体输出。
Cell Mol Life Sci. 2020 Nov;77(21):4413-4428. doi: 10.1007/s00018-019-03425-6. Epub 2020 Jan 2.
10
A robust model for quantitative prediction of the silencing efficacy of wild-type and A-to-I edited miRNAs.一种用于定量预测野生型和 A 到 I 编辑 miRNA 沉默效果的稳健模型。
RNA Biol. 2020 Feb;17(2):264-280. doi: 10.1080/15476286.2019.1678364. Epub 2019 Nov 1.
Science. 2012 May 25;336(6084):1037-40. doi: 10.1126/science.1221551. Epub 2012 Apr 26.
4
Improved siRNA/shRNA functionality by mismatched duplex.通过错配双链体提高 siRNA/shRNA 的功能。
PLoS One. 2011;6(12):e28580. doi: 10.1371/journal.pone.0028580. Epub 2011 Dec 9.
5
Dicer is dispensable for asymmetric RISC loading in mammals.Dicer 在哺乳动物中非对称 RISC 加载中可有可无。
RNA. 2012 Jan;18(1):24-30. doi: 10.1261/rna.029785.111. Epub 2011 Nov 21.
6
Male germ cells express abundant endogenous siRNAs.雄性生殖细胞表达丰富的内源性 siRNAs。
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13159-64. doi: 10.1073/pnas.1108567108. Epub 2011 Jul 25.
7
Current progress of siRNA/shRNA therapeutics in clinical trials.siRNA/shRNA 治疗药物在临床试验中的当前进展。
Biotechnol J. 2011 Sep;6(9):1130-46. doi: 10.1002/biot.201100054. Epub 2011 Jul 11.
8
Multilayer checkpoints for microRNA authenticity during RISC assembly.多层面检查点确保 RISCs 组装过程中 microRNA 的真实性。
EMBO Rep. 2011 Sep 1;12(9):944-9. doi: 10.1038/embor.2011.128.
9
siRNA repositioning for guide strand selection by human Dicer complexes.通过人 Dicer 复合物对 siRNA 进行重定位以选择引导链。
Mol Cell. 2011 Jul 8;43(1):110-21. doi: 10.1016/j.molcel.2011.05.028.
10
Crystal structure of the MID-PIWI lobe of a eukaryotic Argonaute protein.真核 Argonaute 蛋白 MID-PIWI 结构域的晶体结构
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10466-71. doi: 10.1073/pnas.1103946108. Epub 2011 Jun 6.